Replies to post #78051 on Biotech Values

[DewDiligence]

ISRG: …the Q4 procedure number was disclosed implicitly, and if you look back at my post where I calculated it, you will be able to verify that this is the case. I made no assumptions; I simply pointed out there were roundoff errors.

Agreed. I misread your post and thought you had made an assumption about the I&A revenue per procedure in 4Q08, but I now see that you didn’t do that and I retract the first paragraph of #msg-37894076.

The second paragraph of #msg-37894076 stands however; the fact that ISRG allows investors to calculate the quarterly procedure count implicitly makes it even odder that they don’t simply disclose the number directly. Is there some benefit to the company in making investors do the extra arithmetic?

This whole thread probably strikes you as a waste of time, but I found it educational. Regards, Dew